Concepedia

Publication | Closed Access

Slow-Release Sodium Fluoride in the Management of Postmenopausal Osteoporosis

DOI

110

Citations

0

References

1994

Year

C. Y. C. Pak, Khashayar Sakhaee, Veronica Piziak, Raymond D. A. Peterson, Neil A. Breslau, John Poindexter, Jan Herzog, A Heard-Sakhaee, Beverley Adams‐Huet, Joan Reisch
Annals of Internal Medicine

Abstract

Intermittent slow-release sodium fluoride plus continuous calcium citrate, administered for about 2.5 years, inhibits new vertebral fractures, increases the mean spinal bone mass without decreasing the radial shaft bone density, and is safe to use.